DataPile investor atlas

Angel investors & venture capitalists in Indiana, United States

Last updated 25-10-2025. Data refreshed weekly.

6 Matches for your filters
16 Total investors in region
3,050 Profiles tracked nationwide
16 Based in Indiana
Indianapolis (6) Largest investor hub
Eli Lilly and Company, Samtec Inc Notable firms

Refine investor results

Toggle multiple filters to narrow the directory instantly.

Location

States & regions

Cities

Industry focus

We found 6 investors with keyword community engagement.

Market intelligence

  • Most active investment themes in Indiana, United States: venture capital & private equity, electrical, electronic manufacturing.
  • 6 profiles are headquartered in Indianapolis, making it the busiest hub in Indiana, United States.
  • Featured firms include Eli Lilly and Company, Samtec Inc, Miles Ahead, American Water.

Explore states in United States

Showing 1 – 6 of 6 investors

Gregg Sengstack profile photo Franklin Electric logo
Gregg Sengstack
Chairman of the Board and Chief Executive Officer
Franklin Electric
Focus areas
electrical electronic manufacturing residential light commercial water systems wastewater systems hvac water systems irrigation industrial water systems engineered products fueling systems metal fabrications consumer discretionary appliances electrical & electronics manufacturing global manufacturer water management fuel management electricity systems pumping systems submersible motors variable frequency drives water treatment agricultural solutions industrial applications municipal infrastructure residential solutions energy sector technical support sustainable practices responsible innovation customer partnership quality assurance safety standards market diversity distribution network intelligent monitoring environmental solutions operational efficiency product reliability service excellence innovative technology critical resources management water systems energy systems pumps motors fuel systems electrical monitoring groundwater distribution sustainable manufacturing environmental impact innovative solutions municipal applications industrial pumps agricultural pumping residential water management electric vehicle charging smart technology pressurization systems predictive maintenance petroleum equipment liquid fuel management oil and gas solutions environmental responsibility water resources energy efficiency renewable energy solutions critical infrastructure monitoring safety systems telecommunications support data center reliability construction water management dewatering solutions solar-powered systems diversity in supply chain community engagement social responsibility corporate governance ethics and compliance employee welfare diversity and inclusion training programs consumer products environmental stewardship corporate foundation clean water initiatives safety training streamlined maintenance b2b e-commerce non-profit government services electronic manufacturing mechanical or industrial engineering automotive environmental services renewables & environment consumer goods consumers consumer internet internet information technology & services nonprofit organization management
Location
Fort Wayne, Indiana, United States
Signals
Katie Kopan profile photo High Alpha logo
Katie Kopan
Associate
High Alpha
Focus areas
venture capital & private equity saas software cloud enterprise software b2b information technology venture capital & private equity principals venture capital b2b saas co-creation startup acceleration funding innovation healthcare software sales enablement supply chain solutions agtech customer engagement minimum viable product founder partnership portfolio companies market entry digital transformation operational support strategic guidance community impact technology solutions early-stage startups corporate innovation saas ecosystem business growth entrepreneurial support market feedback product-market fit venture studio model industry expertise scalable solutions customer advocacy employee scheduling automated bookkeeping conversational intelligence hybrid events management learning management systems audio advertising workplace culture assessments startup incubation founder partnerships capital investment software development scaling solutions ai integration go-to-market strategy market analysis cloud-based applications risk management compliance solutions design resources marketing automation learning management e-commerce solutions data analytics customer relationship management lead generation sales management growth acceleration performance optimization financial forecasting human resources management portfolio management event management community engagement digital marketing remote work solutions personalized marketing performance metrics subscription pricing investment strategy mobile applications customer insights team collaboration tools social media marketing content marketing connected platforms operational efficiency workflow automation data protection supply chain optimization consulting services computer software information technology & services enterprises marketing & advertising consumer internet consumers internet crm sales events services mobile apps
Location
Indianapolis, Indiana, United States
Signals
Marc Kemen profile photo Eli Lilly and Company logo
Marc Kemen
Senior Director - Investor Relations
Eli Lilly and Company
Focus areas
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
Location
Indianapolis, Indiana, United States
Signals
Mike Sprengnether profile photo Eli Lilly and Company logo
Mike Sprengnether
Senior Director, Investor Relations
Eli Lilly and Company
Focus areas
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
Location
Indianapolis, Indiana, United States
Signals
Nicole Dimichele profile photo McDonald's logo
Nicole Dimichele
Greater Indiana Co-op Board of DIrectors
McDonald's
Focus areas
restaurants restaurant sustainability foodservice franchising operations real estate supply chain communications human resources finance it accounting marketing investor relations charities rmhc diversity csr legal insurance consumer discretionary fast food hamburgers cheeseburgers french fries chicken nuggets breakfast items happy meals coffee mccafé value meals family-friendly affordable pricing quick service drive-thru mobile ordering delivery loyalty program customer experience nutritional options global presence diverse menu localized offerings community engagement innovative flavors brand loyalty convenience multi-generational appeal health-conscious choices restaurant experience competitive landscape market expansion customer feedback digital services promotional campaigns sustainability initiatives burgers fries chicken sandwiches mcnuggets happy meal breakfast menu value menu beverages sweets deals app offers mymcdonald's rewards mcdelivery food quality fresh ingredients fresh beef pickup curbside pickup gift cards ronald mcdonald house charities community support food donations nutrition facts calorie counts contactless payment food allergens family meals special promotions kids meals exclusive offers catering restaurant locator employee opportunities menu variety food sourcing sustainability efforts scholarships digital apps loyalty points meal deals seasonal menu items b2c e-commerce non-profit services retail environmental services renewables & environment franchises financial services consumer internet consumers internet information technology & services nonprofit organization management coffee & tea food restaurants
Location
Westfield, Indiana, United States
Signals
Susan Hedglin profile photo Eli Lilly and Company logo
Susan Hedglin
Senior Director, Investor Relations
Eli Lilly and Company
Focus areas
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
Location
Indianapolis, Indiana, United States
Signals

Explore other regions in United States